证券代码：300313 证券简称：*ST天山 公告编号：2023-072 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）第五届监事会 2023 年第二次临时会议（以下简称"本次会议"）通知及会议材料于 2023 年 8 月 19 日以书面和电子邮件方式发出。本次会议于 2023 年 8 月 24 日下午 16:30 在新疆昌吉市宁边西路 262 号会议室以现场会议结合通讯方式召开。 本次会议由监事李金针女士主持，应参加监事 3 名，实际参加监事 3 名（其 中监事会主席刘军先生、监事张君女士以通讯表决方式出席会议）。本次会议符 合《中华人民共和国公司法》及《公司章程》的有关规定，合法有效。经与会监 事认真审议，通过了如下议案。 二、监事会会议审议情况 （一）审议通过《公司 2023 年半年度报告及摘要》 公司监事会全体监事表决同意《公司 2023 年半年度报告及摘要》。监事会 认为：董事会编制和审核新疆天山畜牧生物工程股份有限公司 2023 年半年度报 告及摘要的程序符合法律、行政法 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：300313 证券简称：*ST天山 公告编号：2023-077 新疆天山畜牧生物工程股份有限公司 关于召开 2023 年第五次临时股东大会的通知 根据《公司法》和《公司章程》的有关规定，经新疆天山畜牧生物工程股份 有限公司（以下简称"公司"）第五届董事会 2023 年第七次临时会议审议通过， 公司决定于 2023 年 9 月 11 日在新疆昌吉市宁边西路 262 号公司会议室召开 2023 年第五次临时股东大会。现将会议有关事项通知如下： 一、召开会议的基本情况 （1）现场会议召开时间：2023 年 9 月 11 日下午 15:00（北京时间）。 （2）网络投票时间： 1）通过深圳证券交易所交易系统进行网络投票的时间为：2023 年 9 月 11 日上午 9:15-9:25，9:30-11:30，下午 13:00-15:00； 2）通过互联网投票系统进行网络投票的时间为：2023 年 9 月 11 日上午 9:15 至 2023 年 9 月 11 日 15:00 期间的任意时间。 5、会议的召开方式：本 ...

编号：2023-02 | | □ 特定对象调研 □ 分析师会议 | | --- | --- | | 投资者关系活动 | 业绩说明会 □ 媒体采访 √ | | 类别 | □ 新闻发布会 □ 路演活动 | | | □ 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 投资者网上提问 | | 人员姓名 | | | 时间 | 2023 年 6 月 16 日 (周五) 15:00-18:00 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召开业绩说明会 | | 上市公司接待人 | 董事长：马长水先生 | | 员姓名 | 财务总监：陈越凡女士 | | | 董事、副总经理、董事会秘书：韩明辉先生 | | | 公司于 2023 年 6 月 16 日 15:00-18:00 通过全景网"投资者 | | | 关系互动平台"（https://ir.p5w.net）采用网络远程的方式召 | | | 开业绩说明会。主要问题如下： | | | 1、股价持续低迷，控股股东是否考虑回购股份？ | | | 感谢您的提问。公司暂 ...

证券代码：300313 证券简称：*ST天山 公告编号：2023-058 新疆天山畜牧生物工程股份有限公司 关于参加新疆辖区上市公司 2023 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）将参加由新疆证 监局、新疆上市公司协会与深圳市全景网络有限公司联合举办的"2023 年新疆 辖区上市公司投资者集体接待日活动"，加强与投资者的互动交流。现将相关事 项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net）或关注微信公众号：全景财经，或下载全景路演 APP， 参与本次互动交流，活动时间为 2023 年 6 月 16 日（周五）15:30-18:00。届时 公司高管将在线就公司 2022 年度业绩、公司治理、发展战略、经营状况、融资 计划、股权激励和可持续发展等投资者关心的问题，与投资者进行沟通交流，欢 迎广大投资者踊跃参与。 特此公告。 新疆天山畜牧生物工程股份有限公司董事会 二〇二三年六月八日 ...

编号：2023-01 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活 | □媒体采访 √业绩说明会 | | 动类别 | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 线上参与公司天山生物 2022 年度网上业绩说明会的投资者 | | 时间 | 2023 年 05 月 19 日（星期五）15:00-17:00 | | 地点 | "天山生物投资者关系"微信小程序 | | 上市公司接待 人员姓名 | 董事长：马长水先生 董事、副总经理、董事会秘书：韩明辉先生 | | | 总经理：葛建军先生 | | | 财务总监：陈越凡女士 | | | 独立董事：吴武清先生 | | 投资者关系活 | 公司于 2023 年 5 月 19 日 15:00-17:00 在"天山生物投 1、问：马董您好：公司今年有再融资的打算吗，或者说 公司今年购买优质资产的打算吗？ | | | 资者关系"微信小程序采用网络远程方式举行 2022 年度网上 | | | 业绩说明会。 | | | 答：感谢您的提问。公司年度审计报告 ...

Financial Performance - The company's revenue for Q1 2023 was CNY 23,156,538.66, representing an increase of 85.05% compared to CNY 12,513,598.14 in the same period last year[4] - The net profit attributable to shareholders was a loss of CNY 4,015,972.23, an improvement of 14.63% from a loss of CNY 4,704,224.83 in the previous year[4] - Total operating revenue for Q1 2023 was CNY 23,156,538.66, an increase of 85.4% compared to CNY 12,513,598.14 in the same period last year[28] - The net profit for Q1 2023 was -4,187,542.06 CNY, compared to -4,850,052.66 CNY in Q1 2022, indicating a 13.7% improvement year-over-year[29] - Operating profit for Q1 2023 was -3,577,013.03 CNY, an improvement from -4,253,297.33 CNY in the same period last year, reflecting a 15.9% increase[29] - The company reported a total comprehensive loss of -4,187,542.06 CNY for Q1 2023, compared to a loss of -2,339,570.19 CNY in Q1 2022[30] - Basic and diluted earnings per share for Q1 2023 were both -0.0128 CNY, compared to -0.0150 CNY in Q1 2022[30] Cash Flow and Assets - The net cash flow from operating activities decreased by 60.96% to CNY 5,336,772.76, down from CNY 13,668,439.97 in the same period last year[4] - Current assets totaled CNY 103,617,004.82 as of March 31, 2023, down 11.9% from CNY 117,638,304.71 at the beginning of the year[25] - The company's cash and cash equivalents were CNY 45,331,434.33, a decrease of 4.1% from CNY 47,288,291.92 at the start of the year[24] - Cash and cash equivalents at the end of Q1 2023 were 45,331,434.33 CNY, down from 122,047,971.83 CNY at the end of Q1 2022, representing a 62.9% decline[33] - The total assets at the end of the reporting period were CNY 316,181,952.90, a decrease of 4.81% from CNY 332,145,607.55 at the end of the previous year[4] - Total liabilities decreased to CNY 226,201,543.59 from CNY 237,977,656.18, a reduction of 5.2%[26] Operating Costs and Income - The operating costs rose by 112.71% to CNY 20,922,380.31, compared to CNY 9,835,924.63 in the previous year, reflecting increased sales activity[9] - Total operating costs for Q1 2023 were CNY 27,560,427.12, up 50.1% from CNY 18,369,110.26 in Q1 2022[28] - Operating costs included CNY 20,922,380.31 in cost of goods sold, which rose significantly from CNY 9,835,924.63 in the previous year, reflecting a 112.5% increase[28] - The company reported a significant increase in operating income, primarily due to a rise in live livestock sales volume[9] - The company recorded a 170.30% increase in other operating income, amounting to CNY 118,716.00, mainly from the sale of patent technology[9] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,618[11] - As of the report date, the controlling shareholder, Huzhou Haohui, holds 69,211,312 shares, representing 22.11% of the total share capital, with 15,350,000 shares pledged[16] - Chen Dehong holds 37,279,083 shares, accounting for 11.91% of the total share capital, with 36,509,768 shares pledged and all shares frozen[17] Legal and Regulatory Issues - The company was involved in a significant legal case regarding contract fraud, resulting in a judgment that included the return of 37,279,083 shares from Chen Dehong and 78,345,524 shares from other shareholders[20] - The company faced a major loss due to fraudulent activities during the acquisition of Daxiang Advertising, leading to a criminal case against involved parties[20] - The company has been actively pursuing legal actions to recover losses from the fraudulent acquisition, with ongoing litigation against 33 parties involved in the stock transfer dispute[21] - The total transaction price for acquiring 96.21% of Daxiang Advertising was 2,372.6142 million yuan[14] - The company is currently awaiting the outcome of an appeal related to the stock transfer dispute, which has not yet been heard in the second instance[21] Investment and Development - The company's cash inflow from investment activities was CNY 148,172.00, a significant increase from CNY 0.00 in the previous year[10] - Research and development expenses for Q1 2023 were 181,359.78 CNY, a decrease of 16.7% from 217,754.69 CNY in Q1 2022[29] Agricultural Policy Impact - In Q1 2023, the government allocated a total of 20,300 acres for agricultural planting, reflecting a decrease in available planting area due to water resource management policies[19] - The company has been adjusting its operational strategies in response to changes in agricultural policies and legal challenges[19]

Financial Performance - The company's net profit for the reporting period was negative, primarily due to lower-than-expected revenue from live livestock business, resulting in overall gross profit and profitability not meeting expectations[8]. - Non-operating losses impacted net profit, with a reduction of 9.2027 million yuan, and a foreign currency translation difference from the disposal of an overseas subsidiary reduced net profit by 10.0362 million yuan[9]. - The company's operating revenue for 2022 was ¥76,350,268.21, a decrease of 29.29% compared to ¥107,976,195.34 in 2021[29]. - The net profit attributable to shareholders was -¥31,848,222.21, representing a decline of 16.65% from -¥27,302,573.67 in the previous year[29]. - The net profit after deducting non-recurring gains and losses was -¥22,645,548.15, an improvement of 63.79% compared to -¥62,540,184.58 in 2021[29]. - The cash flow from operating activities was -¥7,565,896.10, showing a significant improvement of 78.42% from -¥35,061,014.17 in the previous year[29]. - The total assets at the end of 2022 were ¥332,145,607.55, a decrease of 16.80% from ¥842,790,652.79 at the end of 2021[29]. - The net assets attributable to shareholders decreased by 19.08% to ¥84,261,480.39 from ¥104,129,406.24 in 2021[29]. - The basic earnings per share for 2022 was -¥0.10, a decline of 11.11% from -¥0.09 in the previous year[29]. - The company reported a significant reduction in operating revenue after deductions, amounting to ¥72,077,741.50 in 2022 compared to ¥105,380,686.29 in 2021[30]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the negative net profit figures over the last three accounting years[29]. Business Strategy and Market Position - The company aims to return to its core competencies in breeding and fattening after experiencing challenges from cross-industry mergers and acquisitions[4]. - The company is positioned to address China's significant beef consumption gap, which is approximately 10 million tons annually, with nearly 3 million tons relying on imports[4]. - The company has established a solid foundation in the breeding sector, particularly in Tongliao, known as the hometown of Simmental cattle[4]. - The company emphasizes the importance of breeding as a fundamental solution to meet domestic beef consumption needs[4]. - The company is focused on improving meat cattle production efficiency and quality through innovation and modern breeding techniques[42]. - The company aims to enhance its competitive advantage by implementing cost-reduction strategies and collaborating with upstream and downstream partners[41]. - The company plans to develop beef cattle fattening industries in key breeding areas such as Xinjiang and Inner Mongolia, focusing on capital, management, and technology integration[54]. - The company is expanding its influence in the beef market, particularly in regions with a long history of cattle breeding, such as Inner Mongolia[66]. Industry Context and Challenges - The meat cattle breeding industry is experiencing a supply-demand imbalance, with China importing approximately 3 million tons of beef annually[41]. - The domestic meat cattle farming industry is still in its early stages, with only 4.1% of farms having over 1,000 heads of cattle[45]. - The gap between domestic beef consumption and production has widened significantly, with a consumption gap of 2.69 million tons in 2022, which is 26% of total consumption[46]. - The Chinese government aims to achieve a beef self-sufficiency rate of approximately 85% by 2025, as outlined in various policy documents[48]. - The average annual per capita beef consumption in China is only 7.3 kg, significantly lower than Argentina's 64.2 kg, indicating substantial growth potential[46]. - The compound annual growth rate (CAGR) of domestic beef consumption from 2012 to 2021 exceeded 50%, highlighting increasing demand[46]. Governance and Management - The company has established a comprehensive internal control system to enhance governance and compliance with relevant laws and regulations[130]. - The company maintains independence from its controlling shareholder in terms of operations, assets, and finances, ensuring autonomous decision-making capabilities[135]. - The company has committed to transparent information disclosure, ensuring all shareholders have equal access to information[133]. - The company has actively respected and maintained the rights of stakeholders, promoting balanced interests among shareholders, employees, and society[134]. - The company has a structured approach to determining the remuneration of its executives, ensuring alignment with shareholder interests[151]. - The company has a significant focus on compliance and governance, as evidenced by the legal qualifications of its management team[147]. - The company has pledged to avoid any competitive business activities that may conflict with the operations of the listed company and its subsidiaries[180]. Legal and Regulatory Issues - The company is actively pursuing legal actions related to a contract fraud case involving the restructured Elephant Advertising, with ongoing court proceedings[77]. - The company faced disciplinary actions from the Shenzhen Stock Exchange and the China Securities Regulatory Commission due to failures in timely and accurate disclosures related to significant investments and related party transactions[150]. - The company has received an administrative penalty of 300,000 yuan from the China Securities Regulatory Commission for information disclosure violations related to a major asset restructuring[126]. - The company is in the process of addressing legal issues related to the former actual controller's contract fraud case, which may impact its financial reporting[199]. Future Outlook and Plans - The company plans to focus on the Chinese beef cattle industry, aiming to become a leading enterprise by implementing a "big beef cattle strategy" that includes breeding and beef cattle farming[112]. - The company aims to enhance its breeding business and beef cattle farming, aiming to stabilize and improve profitability through effective operational management and cost control[117]. - In 2023, the company aims to restart its meat business, leveraging its proximity to the Beijing-Tianjin-Hebei market and the availability of beef sources[118]. - The company intends to optimize its asset structure and reduce financial risks by disposing of idle assets and seeking direct financing[119]. - The company has committed to sustainability initiatives, targeting a 20% reduction in carbon emissions by 2025[189]. Employee and Stakeholder Engagement - The total number of employees at the end of the reporting period was 107, with 16 in the parent company and 91 in major subsidiaries[163]. - Employee training programs are implemented to enhance skills and management capabilities, combining internal and external training[165]. - The company has not implemented any employee stock ownership plans or other employee incentive measures during the reporting period[168]. - The independent directors fulfilled their responsibilities in the profit distribution process, ensuring shareholder interests were protected[166].

证券代码：300313 证券简称：ST天山 公告编号：2023-048 投资者依据提示，授权登入"天山生物投资者关系"小程序，即可参与交流。 出席本次年度业绩网上说明会的人员有：董事长马长水先生；总经理葛建军 先生；董事、副总经理、董事会秘书韩明辉先生；财务总监陈越凡女士；独立董 事吴武清先生。 公司将在 2022 年度网上业绩说明会上，对投资者普遍关注的问题进行回答。 在业绩交流会期间，投资者仍可登录活动界面进行互动提问。欢迎广大投资者积 极参与本次年度业绩网上说明会。 新疆天山畜牧生物工程股份有限公司 关于举行 2022 年度网上业绩说明会并征集相关问题的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 新疆天山畜牧生物工程股份有限公司（以下简称"公司"）《2022 年年度 报告》及《2022 年年度报告摘要》已于 2023 年 4 月 26 日刊登于中国证监会指 定的创业板信息披露网站巨潮资讯网（www.cninfo.com.cn）。 为便于广大投资者更深入全面地了解公司情况，公司定于 2023 年 5 月 19 日（星期五）下午 15:00 至 1 ...

证券代码：300313 证券简称：天山生物 新疆天山畜牧生物工程股份有限公司 投资者关系活动记录表 编号：2015-01 | --- | --- | --- | |----------------|--------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | ■ 特定对象调研 | □ 分析师会议 | | 投资者关系活动 | □ 媒体采访 | □ 业绩说明会 | | 类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | | 长城新盛信托有限责任公司：曾江 ...

证券代码：300313 证券简称：天山生物 新疆天山畜牧生物工程股份有限公司 投资者关系活动记录表 编号：2016-01 | --- | --- | --- | |----------------|-----------------------------|----------------------------------------------------------| | | | | | | √特定对象调研 | □ 分析师会议 | | 投资者关系活动 | □ 媒体采访 | □ 业绩说明会 | | 类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 西南证券股份有限公司 徐卿 | | | 人员姓名 | | | | 时间 | 2016 年 6 月 2 日 | | | 地点 | 东方广场二十楼公司会议室 | | | 上市公司接待人 | | | | 员姓名 | 证券事务代表 于舒玮 | | | 投资者关系活动 | 1 、大肉牛战略实施情况 | | | 主要内容介绍 | 公司从 2014 | 年开始实施大肉牛战 ...